Table 1 Serotype survey.

Shown is the potential coverage (percent) of a trivalent GBS vaccine in various countries. Data are extrapolated from (16) and (21).

Early-onset disease Late-onset disease
Serotype USAGermanyUKS AfricaMalawiUSAGermanyUKS AfricaMalawi
Ia30173223262411171420
Ib7565774704
III28583758525177678472
Trivalent
(Ia+Ib+III)
65807586858292929896